| |
| | Experts tackle issues raised by race-based drugs - MIT News Office |
 | | Scientists and scholars specializing in medicine, public health, social sciences, ethics and law will convene at MIT on Friday and Saturday, April 7 and 8, for a groundbreaking conference on the complex implications of such drugs as BiDil, a heart medication approved by the FDA in 2005 for treating patients who identify themselves as fl. |
 | | The crossdisciplinary discussion, titled "Race, Pharmaceuticals and Medical Technology," was organized by the Center for the Study of Diversity in Science, Technology and Medicine (CSD) at MIT. |
 | | Race, Pharmaceuticals, and Medical Technology - April 7-8, 2006, at MIT. |
| web.mit.edu /newsoffice/2006/sts-0405.html (539 words) |
|